Replaces Prod. #: ALX-480-087
A cell-permeable cGMP antagonist which is resistant to hydrolysis by cyclic nucleotide phosphodiesterases (Ki=0.5 µM). No metabolic side effects. Significantly more lipophilic and membrane permeant as compared to Rp-cGMPS (Prod. No. ALX-480-072) or Rp-8-Br-cGMPS (Prod. No. BML-CN216)
Product Details
Formula: | C16H14N5O6PS2Cl . Na |
|
MW: | 525.9 |
|
CAS: | 153660-04-9 |
|
Purity: | ≥98% (HPLC) |
|
Appearance: | White solid. |
|
Solubility: | Soluble in water (25 mg/ml). |
|
Shipping: | Ambient Temperature |
|
Long Term Storage: | -20°C |
|
Use/Stability: | Store, as supplied, at -20°C for up to 1 year. Store solutions at -20°C for up to 3 months. |
|
Regulatory Status: | RUO - Research Use Only |
|
Please mouse over
Product Literature References
Green tea catechins enhance norepinephrine-induced lipolysis via a protein kinase A-dependent pathway in adipocytes: S. Chen, et al.; Biochem. Biophys. Res. Commun.
461, 1 (2015),
Application(s): Cell Culture,
Abstract;
Antagonists of cyclic nucleotide-gated channels and molecular mapping of their site of action: R.H. Kramer & G.R. Tibbs ; J. Neurosci.
16, 1285 (1996),
Abstract;
The type II isoform of cGMP-dependent protein kinase is dimeric and possesses regulatory and catalytic properties distinct from the type I isoforms: D.M. Gamm et al.; J Biol Chem
270, 27380 (1995),
Abstract;
(Rp)-8-pCPT-cGMPS, a novel cGMP-dependent protein kinase inhibitor: E. Butt et al.; Eur. J. Pharmacol.
269, 265 (1994),
Abstract;